Thrombotic Complications after COVID-19 Vaccination: Diagnosis and Treatment Options
Open Access
- 26 May 2022
- journal article
- review article
- Published by MDPI AG in Biomedicines
- Vol. 10 (6), 1246
- https://doi.org/10.3390/biomedicines10061246
Abstract
Coronavirus disease 2019 (COVID-19) vaccines were developed a few months after the emergence of the pandemic. The first cases of vaccine-induced thrombotic complications after the use of adenoviral vector vaccines ChAdOx1 nCoV-19 by AstraZeneca, and Ad26.COV2.S by Johnson & Johnson/Janssen, were announced shortly after the initiation of a global vaccination program. In these cases, the occurrence of thrombotic events at unusual sites—predominantly located in the venous vascular system—in association with concomitant thrombocytopenia were observed. Since this new entity termed vaccine-induced thrombotic thrombocytopenia (VITT) shows similar pathophysiologic mechanisms as heparin-induced thrombocytopenia (HIT), including the presence of antibodies against heparin/platelet factor 4 (PF4), standard routine treatment for thrombotic events—arterial or venous—are not appropriate and may also cause severe harm in affected patients. Thrombotic complications were also rarely documented after vaccination with mRNA vaccines, but a typical VITT phenomenon has, to date, not been established for these vaccines. The aim of this review is to give a concise and feasible overview of diagnostic and therapeutic strategies in COVID-19 vaccine-induced thrombotic complications.This publication has 54 references indexed in Scilit:
- Spontaneous heparin-induced thrombocytopenia syndrome: 2 new cases and a proposal for defining this disorderBlood, 2014
- The severity of trauma determines the immune response to PF4/heparin and the frequency of heparin-induced thrombocytopeniaBlood, 2010
- Fatal heparin‐induced thrombocytopenia (HIT) during warfarin thromboprophylaxis following orthopedic surgery: another example of ‘spontaneous’ HIT?Journal of Thrombosis and Haemostasis, 2008
- A Spontaneous Prothrombotic Disorder Resembling Heparin-induced ThrombocytopeniaThe American Journal of Medicine, 2008
- Adenovirus-Platelet Interaction in Blood Causes Virus Sequestration to the Reticuloendothelial System of the LiverJournal of Virology, 2007
- Adenovirus-induced thrombocytopenia: the role of von Willebrand factor and P-selectin in mediating accelerated platelet clearanceBlood, 2006
- Role of platelet surface PF4 antigenic complexes in heparin-induced thrombocytopenia pathogenesis: diagnostic and therapeutic implicationsBlood, 2006
- Thrombosis of the Cerebral Veins and SinusesThe New England Journal of Medicine, 2005
- Thrombosis of the Cerebral Veins and SinusesThe New England Journal of Medicine, 2005
- Pentosan polysulfate‐induced thrombocytopenia and thrombosisAmerican Journal of Hematology, 1994